Your browser doesn't support javascript.
loading
Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.
Wang, Chao; Li, Yan; Chu, Chuan-Min; Zhang, Xiang-Min; Ma, Jie; Huang, Hai; Wang, Yu-Ning; Hong, Tian-Yu; Zhang, Jing; Pan, Xiu-Wu; Zheng, Jing-Cun; Jiang, Ning; Hu, Chuan-Yi; Ma, Xiaojing; Sun, Ying-Hao; Cui, Xin-Gang.
Afiliação
  • Wang C; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), 168 Changhai Road, Shanghai 200438, China.
  • Li Y; Ningxia Medical University, Yinchuan, Ningxia 750004, China; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China.
  • Chu CM; Department of Urinary Surgery, The Third Affiliated Hospital of Second Military Medical University (Eastern Hepatobiliary Surgery Hospital), 700 North Moyu Road, Shanghai 201805, China; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219
  • Zhang XM; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China.
  • Ma J; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China.
  • Huang H; Department of Urinary Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin Road No. 2, Shanghai 200025, China.
  • Wang YN; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China; Ningxia Medical University, Yinchuan, Ningxia 750004, China.
  • Hong TY; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China; Ningxia Medical University, Yinchuan, Ningxia 750004, China.
  • Zhang J; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China.
  • Pan XW; Department of Urinary Surgery, The Third Affiliated Hospital of Second Military Medical University (Eastern Hepatobiliary Surgery Hospital), 700 North Moyu Road, Shanghai 201805, China.
  • Zheng JC; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China.
  • Jiang N; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China.
  • Hu CY; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China. Electronic address: huchuanyi2001@163.com.
  • Ma X; Department of Microbiology and Immunology, Weill Medical College of Cornell University, 1300 York Avenue, New York 10065-4805, NY, United States.. Electronic address: xim2002@med.cornell.edu.
  • Sun YH; Department of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), 168 Changhai Road, Shanghai 200438, China. Electronic address: sunyhsmmu@126.com.
  • Cui XG; Department of Urinary Surgery, Gongli Hospital, Second Military Medical University (Naval Medical University), 219 Miaopu Road, Shanghai 200135, China; Department of Urinary Surgery, The Third Affiliated Hospital of Second Military Medical University (Eastern Hepatobiliary Surgery Hospital), 700 Nor
EBioMedicine ; 39: 255-264, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30558998

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Regulação para Cima / Proteínas Proto-Oncogênicas / Resistencia a Medicamentos Antineoplásicos / Complexo de Endopeptidases do Proteassoma / Neoplasias Renais Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Animals / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: EBioMedicine Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Regulação para Cima / Proteínas Proto-Oncogênicas / Resistencia a Medicamentos Antineoplásicos / Complexo de Endopeptidases do Proteassoma / Neoplasias Renais Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Animals / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: EBioMedicine Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Holanda